Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:clinical_trial
|
| gptkbp:clinicalTrials.gov_Identifier |
NCT02154490
|
| gptkbp:collaboratesWith |
gptkb:Friends_of_Cancer_Research
gptkb:FDA gptkb:Foundation_Medicine |
| gptkbp:designer |
biomarker-driven
|
| gptkbp:focus |
gptkb:non-small_cell_lung_cancer
|
| gptkbp:fullName |
Lung Cancer Master Protocol
|
| https://www.w3.org/2000/01/rdf-schema#label |
S1400 (Lung-MAP trial)
|
| gptkbp:location |
gptkb:United_States
|
| gptkbp:period |
Phase II/III
|
| gptkbp:purpose |
test multiple targeted therapies
|
| gptkbp:sponsor |
gptkb:National_Cancer_Institute
gptkb:SWOG_Cancer_Research_Network |
| gptkbp:startYear |
2014
|
| gptkbp:status |
active, not recruiting
|
| gptkbp:studyType |
umbrella trial
|
| gptkbp:targetAudience |
patients with advanced squamous cell lung cancer
|
| gptkbp:website |
https://www.lung-map.org/
|
| gptkbp:bfsParent |
gptkb:SWOG_Cancer_Research_Network
|
| gptkbp:bfsLayer |
7
|